Cargando…
Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
BACKGROUND: Lung cancer (LC) is a common malignant tumor with a high incidence and poor prognosis. Early LC could be cured, but the 5-year-survival rate for patients advanced is extremely low. Early screening of tumor biomarkers through plasma could allow more LC to be detected at an early stage, le...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677906/ https://www.ncbi.nlm.nih.gov/pubmed/36404333 http://dx.doi.org/10.1186/s12014-022-09381-x |